secwatch / observer
8-K filed April 25, 2023, 7:59 PM ET CIK 0001865861
other material confidence high sentiment neutral materiality 0.70

Cactus Acquisition Corp. 1 extends deadline to Nov 2, 2023; 10.2M shares redeemed

Cactus Acquisition Corp. 1 Ltd

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Cactus Acquisition Corp. 1 Ltd: Conversion Amendment allowing Class B ordinary shares to convert into Class A ordinary shares on a one-for-one basis prior to business combination.

Change
charter amendment
Exact text from the filing
The Conversion Amendment amends certain provisions of the Amended and Restated Articles in order to allow each holder of the Company’s Class B ordinary shares, par value $0.0001 per share (“Class B ordinary shares ”) to convert such shares into the Company’s Class A ordinary shares on a one-for-one basis prior to the closing of a business combination, at the election of such holder.
View on SEC.gov
Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Cactus Acquisition Corp. 1 Ltd: Extension Amendment extending the deadline for business combination from May 2, 2023 to November 2, 2023 (effective 2023-05-02).

Change
charter amendment
Effective
2023-05-02
Exact text from the filing
The Extension Amendment extends the date by which the Company must consummate its initial business combination from May 2, 2023 to November 2, 2023, or such earlier date as determined by the Company’s board of directors.
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Cactus Acquisition Corp. 1 Ltd shareholders approved Election of five directors: Ofer Gonen, Nachum (Homi) Shamir, Hadar Ron, M.D., David J. Shulkin, M.D., and David Sidransky, M.D. at the 2023-04-20 meeting.

Proposal
director election
Outcome
passed
Meeting
2023-04-20
Exact text from the filing
The Director Proposal was approved, and each of Ofer Gonen, Nachum (Homi) Shamir, Hadar Ron, M.D., David J. Shulkin, M.D., and David Sidransky, M.D. was re-elected to the Company’s board of directors. The voting results of the Class B ordinary shares for each of the nominees was as follows: For Against Abstain 3,162,500 0 0
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Cactus Acquisition Corp. 1 Ltd shareholders approved Approval of Trust Extension Proposal to amend Trust Agreement to extend business combination deadline from May 2, 2023 to November 2, 2023 at the 2023-04-20 meeting.

Proposal
merger approval
Outcome
passed
Meeting
2023-04-20
Exact text from the filing
The Trust Extension Proposal was approved. The voting results of the Ordinary Shares were as follows: For Against Abstain 11,270,029 1,466,596 0
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Cactus Acquisition Corp. 1 Ltd shareholders approved Approval of Extension Amendment to Amended and Restated Articles to extend business combination deadline from May 2, 2023 to November 2, 2023 at the 2023-04-20 meeting.

Proposal
charter amendment
Outcome
passed
Meeting
2023-04-20
Exact text from the filing
The Articles Extension Proposal was approved. The voting results of the Ordinary Shares were as follows: For Against Abstain 11,270,029 1,466,596 0
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Cactus Acquisition Corp. 1 Ltd shareholders approved Approval of Conversion Amendment to Amended and Restated Articles to allow Class B ordinary shares to convert to Class A ordinary shares on a one-for-one basis prior to business combination at the 2023-04-20 meeting.

Proposal
charter amendment
Outcome
passed
Meeting
2023-04-20
Exact text from the filing
The Conversion Amendment Proposal was approved. The voting results of the Ordinary Shares were as follows: For Against Abstain 11,270,029 1,466,596 0
View on SEC.gov

Browse all governance changes →

Source: SEC EDGAR
accession 0001213900-23-032483
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.